Page last updated: 2024-10-31

nafamostat and Edema, Pulmonary

nafamostat has been researched along with Edema, Pulmonary in 2 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sendo, T1
Itoh, Y1
Goromaru, T1
Sumimura, T1
Saito, M1
Aki, K1
Yano, T1
Oishi, R1
Naka, Y1
Hirose, H1
Matsuda, H1
Nakano, S1
Shirakura, R1
Kawaguchi, A1
Miyamoto, Y1
Miyagawa, S1
Fukushima, N1
Kawashima, Y1

Other Studies

2 other studies available for nafamostat and Edema, Pulmonary

ArticleYear
A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium.
    British journal of pharmacology, 2003, Volume: 138, Issue:5

    Topics: Animals; Benzamidines; Contrast Media; Dose-Response Relationship, Drug; Guanidines; Humans; Male; P

2003
Prevention of pulmonary edema in autoperfusing heart-lung preparation by FUT-175 and leukocyte depletion.
    Transplantation proceedings, 1989, Volume: 21, Issue:1 Pt 2

    Topics: Animals; Benzamidines; Complement Inactivator Proteins; Dogs; Guanidines; Heart; Isotonic Solutions;

1989